Evidence map›Paper›PMID 37452381›Full record

ArticleBiomaterials research2023

Open source board based acoustofluidic transwells for reversible disruption of the blood-brain barrier for therapeutic delivery.

Ke Wang, Chao Sun, Povilas Dumčius, Hongxin Zhang, Hanlin Liao, Zhenlin Wu, Liangfei Tian, Wang Peng, Yongqing Fu, Jun Wei and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomaterials research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 5 countries.

Ke Wang *State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Chao Sun *School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, People's Republic of China.
Povilas DumčiusDepartment of Electrical and Electronic Engineering, School of Engineering, Cardiff University, Cardiff, CF24 3AA, UK.
Hongxin ZhangState Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Hanlin LiaoState Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Zhenlin WuSchool of Optoelectronic Engineering and Instrumentation Science, Dalian University of Technology, Dalian, 116023, People's Republic of China.
Liangfei TianDepartment of Biomedical Engineering, MOE Key Laboratory of Biomedical Engineering, Zhejiang University, Hangzhou, 310027, People's Republic of China.
Wang PengCollege of Engineering Huazhong Agricultural University, Wuhan, 430070, China.
Yongqing FuFaculty of Engineering and Environment, Northumbria University, Newcastle Upon Tyne, NE1 8ST, UK.
Jun WeiiRegene Therapeutics Co., Ltd, Wuhan, 430070, People's Republic of China.
Meng CaiiRegene Therapeutics Co., Ltd, Wuhan, 430070, People's Republic of China.
Yi ZhongDepartment of Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, People's Republic of China.
Xiaoyu LiDepartment of Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, People's Republic of China.
Xin YangDepartment of Electrical and Electronic Engineering, School of Engineering, Cardiff University, Cardiff, CF24 3AA, UK. YangX26@cardiff.ac.uk.
Min CuiState Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China. cuimin@mail.hzau.edu.cn.ORCID http://orcid.org/0000-0001-9691-033X
Huazhong Agricultural University · CNCardiff University · GBHubei Cancer Hospital · CNIo Therapeutics (United States) · USDalian University of Technology · CNNorthumbria University · GBNorthwestern Polytechnical University · CNZhejiang University · CN

Funding

International Exchange Grant IEC/NSFC/201078National Natural Sciences Foundation of China 31872455National Program on Key Research Project of China SQ2022YFD1800030UK Engineering and Physical Sciences Research Council (EPSRC) EP/P018998/1
6 · The paper itself

Abstract

backgroundBlood-brain barrier (BBB) is a crucial but dynamic structure that functions as a gatekeeper for the central nervous system (CNS). Managing sufficient substances across the BBB is a major challenge, especially in the development of therapeutics for CNS disorders.

methodsTo achieve an efficient, fast and safe strategy for BBB opening, an acoustofluidic transwell (AFT) was developed for reversible disruption of the BBB. The proposed AFT was consisted of a transwell insert where the BBB model was established, and a surface acoustic wave (SAW) transducer realized using open-source electronics based on printed circuit board techniques.

resultsIn the AFT device, the SAW produced acousto-mechanical stimulations to the BBB model resulting in decreased transendothelial electrical resistance in a dose dependent manner, indicating the disruption of the BBB. Moreover, SAW stimulation enhanced transendothelial permeability to sodium fluorescein and FITC-dextran with various molecular weight in the AFT device. Further study indicated BBB opening was mainly attributed to the apparent stretching of intercellular spaces. An in vivo study using a zebrafish model demonstrated SAW exposure promoted penetration of sodium fluorescein to the CNS.

conclusionsIn summary, AFT effectively disrupts the BBB under the SAW stimulation, which is promising as a new drug delivery methodology for neurodegenerative diseases.

Indexed as

Acoustofluidic transwellBlood–brain barrierHuman brain microvascular endothelial cellsSurface acoustic waveTransendothelial electrical resistance

Identifiers

PMID37452381
PMCPMC10349484
OpenAlexW4384281932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.